Skip to main content Skip to navigation Skip to accessibility tools
Herefordshire and Worcestershire logo
Return to main H&W ICS website
  • Home
  • About
    • About
    • Corporate
      • Corporate
      • Governance Handbook
      • Publication Scheme
    • NHS Continuing Healthcare
    • Safeguarding
      • Safeguarding
      • Keep me safe...
      • Pick up the Phone Campaign
  • Board Members
  • Meetings
    • Meetings
    • Board papers
    • Past meetings
    • Past Board Papers
  • News
  • Documents
  • Contact us
    • Contact us
    • Stakeholder and Public Liaison and Information Team

Dermatology

You are here:

  1. Home
  2. Documents
  3. Clinical and Prescribing Policies, Guidance and Pathways
  4. Dermatology
Title
Acne Vulgaris - Prescribing Guideline v3.1
Actinic Keratosis - Prescribing Guideline v2.0
Alopecia areata - Advanced Therapy Pathway v1
Atopic Dermatitis - Advanced Therapy Pathway
Atopic Eczema - Prescribing Guideline v2
Disease-Modifying Anti-Rheumatic Drugs (DMARD) - Shared Care Guidance v1.2
Eflornithine (Vaniqa) cream for facial hirsutism - Position Statement v1.1
Emollients - Prescribing Guideline v2.2
Omalizumab, Chronic Spontaneous Urticaria - Advanced Therapy Pathway
Potassium Permanganate - Safe Use Guideline v1.1
Psoriasis - Advanced Therapy Pathway
Psoriasis - Prescribing Guideline v3.0
Topical Corticosteroids - Prescribing Guideline v3.1
Back to Clinical and Prescribing Policies, Guidance and Pathways
Reducing health inequalities
Digital innovation
Health and care services
Get involved
Work for us
Latest news
  • Privacy
  • Accessibility

Accessibility tools

Text size:
Contrast:
Frank Ltd.
Return to header

Last accessibility toolbar action: none available